Breaking News

Quad Technologies Expands After New HQ, Lab Move

The company says the move "changes the game" for Quad Technologies and its customers

Quad Technologies, a provider of cell and gene therapy bioprocessing reagents, has opened a new, larger headquarters and laboratory in order to expand manufacturing capabilities and offer clients quality reagents for gene-modified cell therapy bioprocesses. 


“We are delivering a service and product that no other company currently offers: a unique T-cell activation reagent using patented QuickGel that ensures optimal efficiency and effectiveness. By moving into this larger office and laboratory space with ISO 8 and ISO 7 clean rooms, we are poised for immediate expansion that benefits the biotechnology industry,” said Quad Technologies co-founder and chief executive officer, Sean Kevlahan. 

 

According to the company, along with the facility expansion, their staff is expected to grow up to 70 percent over the next year. 

 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters